Phage | Stability | Latent period (min) | Burst size (PFU/cell) | Host range (Spectrum) | Anti-biofilm Activity | Ex vivo and in vivo Analysis | Ref | |
---|---|---|---|---|---|---|---|---|
pH | Temp. | |||||||
SFQ1 | 5–11 | 50 °C | 10 | 110 | Broad | It effectively disrupts the biofilms formed by E. faecalis | Not determined | [95] |
KEN04 | 3–11 | -80 °C–37 °C | 20 | 138.5 | Broad | Significantly disrupted biofilms and reduced the bacterial population. It could not inhibit the biofilm formation | Not determined | [96] |
HEf13 | 5–12 | 4–60 °C | 25 | 352 | Broad | Not determined | Effective against human dentin ex vivo infection model | [85] |
IME-EF1 | Not determined | Not determined | 25 | 60 | Moderate | Not determined | 60% survival when administered 30Â min after infection and 40% survival when administered 4Â h after infection | [91] |
φEF24C | -- | -- | 30 | 110 | Broad | Not determined | 100% survival when administered 20 min after infection at MOI 0.01 | |
SRG1 | 3–11 | 37–65 °C | 21 | 512 | Narrow | Not determined | Not determined | [79] |
SA14 | 6–9 | 4 °C -75° | 20 | 20 | Narrow | 1.3 log cycles reduction after 2 h at MOI of 100 and reduced bacterial population | Not determined | [40] |
ZAT1 | 5–10 | 4–65 °C | 25 | 1263 | Narrow | 90% biofilm reduction and reduced bacterial population | 100% survival when administered 1 h after infection at MOI of 0.1 | This study |